The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Guangdong Taiantang Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% CNY0.510
America/New_York / 29 apr 2024 @ 03:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 391.05 mill |
| EPS: | -1.210 |
| P/E: | -0.420 |
| Earnings Date: | May 20, 2024 |
| SharesOutstanding: | 766.77 mill |
| Avg Daily Volume: | 12.64 mill |
| RATING 2024-04-29 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Sell | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.420 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.01x |
| Company: PE -0.420 | industry: PE 45.57 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
CNY 0.425 - 0.595 ( +/- 16.67%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY0.510 (0.00% ) |
| Volume | 2.38 mill |
| Avg. Vol. | 12.64 mill |
| % of Avg. Vol | 18.86 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 002433.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
002433.SZ
Guangdong Taiantang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese patent medicines in China. It offers medicines in the forms of creams, ointments, tablets, capsules, pills, and solutions for the areas, including reproductive health, skin health, cardiovascular, cerebrovascular, dermatology, anti-inflammatory, and other areas, as well as acquires, cultivates, processes, and sells Chinese medicinal materials. The company was founded in 1995 and is headquartered in Shantou, China.